Friday funnies: Cell phones linked to cancer

By ACSH Staff — Mar 14, 2014
If you pay attention to health news, it seems like every day, something new is blamed for causing cancer. And how fitting that on the 30th anniversary of the first handheld cell phone, cell

If you pay attention to health news, it seems like every day, something new is blamed for causing cancer. And how fitting that on the 30th anniversary of the first handheld cell phone, cell

The Food Babe Hath Spoken, And Subway Bread Will Still Suck

By ACSH Staff — Mar 14, 2014
would like to nominate Arvind Mahankali to be the next head of the USDA. Why? He is obviously very smart, has an outstanding work ethic, and a superb vocabulary. He may...[Read more].

would like to nominate Arvind Mahankali to be the next head of the USDA. Why? He is obviously very smart, has an outstanding work ethic, and a superb vocabulary. He may...[Read more].

Rates of ADHD prescriptions soar among adults

By ACSH Staff — Mar 13, 2014
It is difficult to ignore a new report released Wednesday by a St. Louis based prescription drug manager, Express Scripts. The data highlights a glaring reality: a near doubling in attention deficit

It is difficult to ignore a new report released Wednesday by a St. Louis based prescription drug manager, Express Scripts. The data highlights a glaring reality: a near doubling in attention deficit

Pap test for cervical cancer may be replaced

By ACSH Staff — Mar 13, 2014
Millions of women worldwide have been tested for cervical cancer, human papillomavirus (HPV) and other problems via the PAP test. The procedure was invented in 1943 by Dr. George Papanicolaou (thus the name), and has become the most widely used cancer-screening test in the world

Millions of women worldwide have been tested for cervical cancer, human papillomavirus (HPV) and other problems via the PAP test. The procedure was invented in 1943 by Dr. George Papanicolaou (thus the name), and has become the most widely used cancer-screening test in the world

Whole genome sequencing: potential for the clinic still not available today

By ACSH Staff — Mar 12, 2014
For years, academic scientists have used whole genome sequencing (WGS) technology to isolate specific genes associated with disease. These days, researchers and clinicians are working to expand its

For years, academic scientists have used whole genome sequencing (WGS) technology to isolate specific genes associated with disease. These days, researchers and clinicians are working to expand its

Today s No News Item: Another supplement, glucosamine, bites the dust

By ACSH Staff — Mar 12, 2014
It should be no surprise to anyone who reads our Dispatch that we at ACSH are not fans of dietary supplements. Our Dr. Josh Bloom has written repeatedly

It should be no surprise to anyone who reads our Dispatch that we at ACSH are not fans of dietary supplements. Our Dr. Josh Bloom has written repeatedly

Hope for hemophiliacs on the horizon

By ACSH Staff — Mar 12, 2014
Hemophilia is a genetic bleeding disorder. It s X-linked, and therefore it affects males overwhelmingly. There are several different types depending on the factor that s lacking. They have one thing in common: the lack of one of the many proteins clotting factors that are involved with blood clotting makes the sufferer of hemophilia prone to bleeding sometimes fatal bleeding from minor injuries or even no injury at all.

Hemophilia is a genetic bleeding disorder. It s X-linked, and therefore it affects males overwhelmingly. There are several different types depending on the factor that s lacking. They have one thing in common: the lack of one of the many proteins clotting factors that are involved with blood clotting makes the sufferer of hemophilia prone to bleeding sometimes fatal bleeding from minor injuries or even no injury at all.

New FDA-approved device to help prevent migraines

By ACSH Staff — Mar 12, 2014
Over ten percent of the U.S. population suffers from migraines, and currently-approved treatments are not always effective and can produce adverse effects. Now, migraine sufferers may be able to get some relief from a newly FDA-approved device. The device is made by a Belgian company, Cephaly

Over ten percent of the U.S. population suffers from migraines, and currently-approved treatments are not always effective and can produce adverse effects. Now, migraine sufferers may be able to get some relief from a newly FDA-approved device. The device is made by a Belgian company, Cephaly